Immunosenescence and the risk of disease modifying therapies in Multiple Sclerosis

被引:0
|
作者
Mehling, M.
机构
基金
瑞士国家科学基金会;
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
FW16-3
引用
收藏
页码:39 / 39
页数:1
相关论文
共 50 条
  • [21] Aging And Disease Modifying Therapies: Relationship In Multiple Sclerosis
    Zhang, Y.
    Gonzalez-Caldito, N.
    Shirani, A.
    Salter, A.
    Cutter, G.
    Culpepper, W., II
    Wallin, M.
    Wolinsky, J.
    Lublin, F. D.
    Stuve, O.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 135 - 136
  • [22] Current disease-modifying therapies in multiple sclerosis
    Kieseier, BC
    Hartung, HP
    SEMINARS IN NEUROLOGY, 2003, 23 (02) : 133 - 145
  • [23] Update on disease-modifying therapies for multiple sclerosis
    Vargas, Diana L.
    Tyor, William R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (05) : 883 - 891
  • [24] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Jai Perumal
    Omar Khan
    Current Treatment Options in Neurology, 2012, 14 : 256 - 263
  • [25] New and emerging disease modifying therapies for multiple sclerosis
    Saidha, Shiv
    Eckstein, Christopher
    Calabresi, Peter A.
    YEAR IN IMMUNOLOGY, 2012, 1247 : 117 - 137
  • [26] Patient education on disease modifying therapies in multiple sclerosis
    Chrysovitsanou, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 136 - 136
  • [27] Using disease-modifying therapies for multiple sclerosis
    不详
    JOURNAL OF ADVANCED NURSING, 2004, 48 (03) : 314 - 314
  • [28] Emerging multiple sclerosis disease-modifying therapies
    Giacomini, Paul S.
    Darlington, Peter J.
    Bar-Or, Amit
    CURRENT OPINION IN NEUROLOGY, 2009, 22 (03) : 226 - 232
  • [29] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Perumal, Jai
    Khan, Omar
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (03) : 256 - 263
  • [30] Cost of disease-modifying therapies for multiple sclerosis
    Brown, Murray G.
    NEUROLOGY, 2015, 84 (21) : E181 - E185